(Q42548704)

2 November 2017

title

Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds (English)

1 reference

2 November 2017

Zapp ML

1

1 reference

2 November 2017

Young DW

2

1 reference

2 November 2017

Kumar A

3

1 reference

2 November 2017

Singh R

4

1 reference

2 November 2017

Boykin DW

5

1 reference

2 November 2017

Wilson WD

6

1 reference

2 November 2017

Green MR

7

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Bioorganic & Medicinal Chemistry

2 November 2017

published in

1 reference

2 November 2017

volume

5

1 reference

2 November 2017

issue

6

1 reference

2 November 2017

page(s)

1149-1155

1 reference

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

The trans-activator gene of HTLV-III is essential for virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

A second post-transcriptional trans-activator gene required for HTLV-III replication

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Human immunodeficiency virus infection of cells arrested in the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

How can HIV replication be controlled?

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

New role for HIV: a vehicle for moving genes into cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Functional dissection of the HIV-1 Rev trans-activator—Derivation of a trans-dominant repressor of Rev function

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Recognition of the high affinity binding site in rev-response element RNA by the Human Immunodeficiency Virus type-1 rev protein

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

On the nature of antibiotic binding sites in ribosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Interaction of antibiotics with functional sites in 16S ribosomal RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Antibiotic inhibition of group I ribozyme function

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Footprinting the sites of interaction of antibiotics with catalytic group I intron RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Effect of base-pair sequence on the conformations and thermally induced transitions in oligodeoxyribonucleotides containing only AT base pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Design and synthesis of RNA-specific groove-binding cations: implications for antiviral drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Dicationic diarylfurans as anti-Pneumocystis carinii agents

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Small changes in cationic substituents of diphenylfuran derivatives have major effects on the binding affinity and the binding mode with RNA helical duplexes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

Messenger RNA Splicing in Yeast: Clues to Why the Spliceosome Is a Ribonucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2897%2900063-1

7 January 2021

10.1016/S0968-0896(97)00063-1

Identifiers

DOI

1 reference

2 November 2017

1 reference